0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Vaccine Adjuvants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: October 2022
|
Report Code: QYRE-Auto-16A8759
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Vaccine Adjuvants Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Vaccine Adjuvants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-16A8759
Report
October 2022
Pages:101
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Human Vaccine Adjuvants market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

In China, the key players of human vaccine adjuvants include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, etc.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Human Vaccine Adjuvants.
The Human Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Human Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
Product Type Insights
Global markets are presented by Human Vaccine Adjuvants type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Human Vaccine Adjuvants are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Human Vaccine Adjuvants Segment by Type

Aluminium Salt Adjuvant
Oil Emulsion Adjuvant
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Human Vaccine Adjuvants market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Human Vaccine Adjuvants market.

Human Vaccine Adjuvants Segment by Application

Commercial
Research
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Human Vaccine Adjuvants market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Human Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Human Vaccine Adjuvants industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine Adjuvants

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Human Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccine Adjuvants Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Aluminium Salt Adjuvant
1.2.3 Oil Emulsion Adjuvant
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Vaccine Adjuvants Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Commercial
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Vaccine Adjuvants Market Size Estimates and Forecasts
2.1.1 Global Human Vaccine Adjuvants Revenue 2017-2028
2.1.2 Global Human Vaccine Adjuvants Sales 2017-2028
2.2 Human Vaccine Adjuvants Market Size by Region: 2022 Versus 2028
2.3 Human Vaccine Adjuvants Sales by Region (2017-2028)
2.3.1 Global Human Vaccine Adjuvants Sales by Region: 2017-2022
2.3.2 Global Human Vaccine Adjuvants Sales Forecast by Region (2023-2028)
2.3.3 Global Human Vaccine Adjuvants Sales Market Share by Region (2017-2028)
2.4 Human Vaccine Adjuvants Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Human Vaccine Adjuvants Revenue by Region: 2017-2022
2.4.2 Global Human Vaccine Adjuvants Revenue Forecast by Region (2023-2028)
2.4.3 Global Human Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
3 Global Human Vaccine Adjuvants by Manufacturers
3.1 Global Top Human Vaccine Adjuvants Manufacturers by Sales
3.1.1 Global Human Vaccine Adjuvants Sales by Manufacturer (2017-2022)
3.1.2 Global Human Vaccine Adjuvants Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Human Vaccine Adjuvants Manufacturers by Revenue
3.2.1 Global Human Vaccine Adjuvants Revenue by Manufacturer (2017-2022)
3.2.2 Global Human Vaccine Adjuvants Revenue Share by Manufacturer (2017-2022)
3.3 Global Human Vaccine Adjuvants Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Human Vaccine Adjuvants Manufacturers Covered: Ranking by Revenue
3.4.2 Global Human Vaccine Adjuvants Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Human Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Human Vaccine Adjuvants Manufacturing Base Distribution, Product Type
3.5.1 Human Vaccine Adjuvants Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Human Vaccine Adjuvants Product Type
3.5.3 Date of International Manufacturers Enter into Human Vaccine Adjuvants Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 GSK
4.1.1 GSK Corporation Information
4.1.2 GSK Description, Business Overview
4.1.3 GSK Human Vaccine Adjuvants Products Offered
4.1.4 GSK Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.1.5 GSK Human Vaccine Adjuvants Sales by Product in 2021
4.1.6 GSK Human Vaccine Adjuvants Sales by Application in 2021
4.1.7 GSK Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.1.8 GSK Recent Developments
4.2 CSL Limited
4.2.1 CSL Limited Corporation Information
4.2.2 CSL Limited Description, Business Overview
4.2.3 CSL Limited Human Vaccine Adjuvants Products Offered
4.2.4 CSL Limited Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.2.5 CSL Limited Human Vaccine Adjuvants Sales by Product in 2021
4.2.6 CSL Limited Human Vaccine Adjuvants Sales by Application in 2021
4.2.7 CSL Limited Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.2.8 CSL Limited Recent Developments
4.3 Croda
4.3.1 Croda Corporation Information
4.3.2 Croda Description, Business Overview
4.3.3 Croda Human Vaccine Adjuvants Products Offered
4.3.4 Croda Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Croda Human Vaccine Adjuvants Sales by Product in 2021
4.3.6 Croda Human Vaccine Adjuvants Sales by Application in 2021
4.3.7 Croda Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.3.8 Croda Recent Developments
4.4 SEPPIC
4.4.1 SEPPIC Corporation Information
4.4.2 SEPPIC Description, Business Overview
4.4.3 SEPPIC Human Vaccine Adjuvants Products Offered
4.4.4 SEPPIC Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.4.5 SEPPIC Human Vaccine Adjuvants Sales by Product in 2021
4.4.6 SEPPIC Human Vaccine Adjuvants Sales by Application in 2021
4.4.7 SEPPIC Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.4.8 SEPPIC Recent Developments
4.5 Sanofi
4.5.1 Sanofi Corporation Information
4.5.2 Sanofi Description, Business Overview
4.5.3 Sanofi Human Vaccine Adjuvants Products Offered
4.5.4 Sanofi Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Sanofi Human Vaccine Adjuvants Sales by Product in 2021
4.5.6 Sanofi Human Vaccine Adjuvants Sales by Application in 2021
4.5.7 Sanofi Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.5.8 Sanofi Recent Developments
4.6 Zhifei Biological
4.6.1 Zhifei Biological Corporation Information
4.6.2 Zhifei Biological Description, Business Overview
4.6.3 Zhifei Biological Human Vaccine Adjuvants Products Offered
4.6.4 Zhifei Biological Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Zhifei Biological Human Vaccine Adjuvants Sales by Product in 2021
4.6.6 Zhifei Biological Human Vaccine Adjuvants Sales by Application in 2021
4.6.7 Zhifei Biological Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.6.8 Zhifei Biological Recent Development
4.7 Escon
4.7.1 Escon Corporation Information
4.7.2 Escon Description, Business Overview
4.7.3 Escon Human Vaccine Adjuvants Products Offered
4.7.4 Escon Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Escon Human Vaccine Adjuvants Sales by Product in 2021
4.7.6 Escon Human Vaccine Adjuvants Sales by Application in 2021
4.7.7 Escon Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.7.8 Escon Recent Development
4.8 Huanuotai Biological
4.8.1 Huanuotai Biological Corporation Information
4.8.2 Huanuotai Biological Description, Business Overview
4.8.3 Huanuotai Biological Human Vaccine Adjuvants Products Offered
4.8.4 Huanuotai Biological Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Huanuotai Biological Human Vaccine Adjuvants Sales by Product in 2021
4.8.6 Huanuotai Biological Human Vaccine Adjuvants Sales by Application in 2021
4.8.7 Huanuotai Biological Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.8.8 Huanuotai Biological Recent Development
4.9 Rico Bio
4.9.1 Rico Bio Corporation Information
4.9.2 Rico Bio Description, Business Overview
4.9.3 Rico Bio Human Vaccine Adjuvants Products Offered
4.9.4 Rico Bio Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Rico Bio Human Vaccine Adjuvants Sales by Product in 2021
4.9.6 Rico Bio Human Vaccine Adjuvants Sales by Application in 2021
4.9.7 Rico Bio Human Vaccine Adjuvants Sales by Geographic Area in 2021
4.9.8 Rico Bio Recent Development
5 Breakdown Data by Type
5.1 Global Human Vaccine Adjuvants Sales by Type (2017-2028)
5.1.1 Global Human Vaccine Adjuvants Sales by Type (2017-2022)
5.1.2 Global Human Vaccine Adjuvants Sales Forecast by Type (2023-2028)
5.1.3 Global Human Vaccine Adjuvants Sales Market Share by Type (2017-2028)
5.2 Global Human Vaccine Adjuvants Revenue Forecast by Type (2017-2028)
5.2.1 Global Human Vaccine Adjuvants Revenue by Type (2017-2022)
5.2.2 Global Human Vaccine Adjuvants Revenue Forecast by Type (2023-2028)
5.2.3 Global Human Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
5.3 Human Vaccine Adjuvants Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Human Vaccine Adjuvants Sales by Application (2017-2028)
6.1.1 Global Human Vaccine Adjuvants Sales by Application (2017-2022)
6.1.2 Global Human Vaccine Adjuvants Sales Forecast by Application (2023-2028)
6.1.3 Global Human Vaccine Adjuvants Sales Market Share by Application (2017-2028)
6.2 Global Human Vaccine Adjuvants Revenue Forecast by Application (2017-2028)
6.2.1 Global Human Vaccine Adjuvants Revenue by Application (2017-2022)
6.2.2 Global Human Vaccine Adjuvants Revenue Forecast by Application (2023-2028)
6.2.3 Global Human Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
6.3 Human Vaccine Adjuvants Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Human Vaccine Adjuvants Market Size YoY Growth 2017-2028
7.2 North America Human Vaccine Adjuvants Market Facts & Figures by Country
7.2.1 North America Human Vaccine Adjuvants Sales by Country (2017-2028)
7.2.2 North America Human Vaccine Adjuvants Revenue by Country (2017-2028)
7.3 North America Human Vaccine Adjuvants Sales by Type
7.4 North America Human Vaccine Adjuvants Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Human Vaccine Adjuvants Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Human Vaccine Adjuvants Market Facts & Figures by Region
8.2.1 Asia-Pacific Human Vaccine Adjuvants Sales by Region (2017-2028)
8.2.2 Asia-Pacific Human Vaccine Adjuvants Revenue by Region (2017-2028)
8.3 Asia-Pacific Human Vaccine Adjuvants Sales by Type
8.4 Asia-Pacific Human Vaccine Adjuvants Sales by Application
9 Europe
9.1 Europe Human Vaccine Adjuvants Market Size YoY Growth 2017-2028
9.2 Europe Human Vaccine Adjuvants Market Facts & Figures by Country
9.2.1 Europe Human Vaccine Adjuvants Sales by Country (2017-2028)
9.2.2 Europe Human Vaccine Adjuvants Revenue by Country (2017-2028)
9.3 Europe Human Vaccine Adjuvants Sales by Type
9.4 Europe Human Vaccine Adjuvants Sales by Application
10 Latin America
10.1 Latin America Human Vaccine Adjuvants Market Size YoY Growth 2017-2028
10.2 Latin America Human Vaccine Adjuvants Market Facts & Figures by Country
10.2.1 Latin America Human Vaccine Adjuvants Sales by Country (2017-2028)
10.2.2 Latin America Human Vaccine Adjuvants Revenue by Country (2017-2028)
10.3 Latin America Human Vaccine Adjuvants Sales by Type
10.4 Latin America Human Vaccine Adjuvants Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Human Vaccine Adjuvants Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Human Vaccine Adjuvants Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Vaccine Adjuvants Sales by Country (2017-2028)
11.2.2 Middle East and Africa Human Vaccine Adjuvants Revenue by Country (2017-2028)
11.3 Middle East and Africa Human Vaccine Adjuvants Sales by Type
11.4 Middle East and Africa Human Vaccine Adjuvants Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Human Vaccine Adjuvants Supply Chain Analysis
12.2 Human Vaccine Adjuvants Key Raw Materials and Upstream Suppliers
12.3 Human Vaccine Adjuvants Clients Analysis
12.4 Human Vaccine Adjuvants Sales Channel and Sales Model Analysis
12.4.1 Human Vaccine Adjuvants Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Human Vaccine Adjuvants Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Human Vaccine Adjuvants Distributors
13 Market Dynamics
13.1 Human Vaccine Adjuvants Industry Trends
13.2 Human Vaccine Adjuvants Market Drivers
13.3 Human Vaccine Adjuvants Market Challenges
13.4 Human Vaccine Adjuvants Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Human Vaccine Adjuvants Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Aluminium Salt Adjuvant
    Table 3. Major Manufacturers of Oil Emulsion Adjuvant
    Table 4. Major Manufacturers of Others
    Table 5. Global Human Vaccine Adjuvants Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Human Vaccine Adjuvants Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 7. Global Human Vaccine Adjuvants Sales by Region (2017-2022) & (Tons)
    Table 8. Global Human Vaccine Adjuvants Sales Forecast by Region (2023-2028) & (Tons)
    Table 9. Global Human Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global Human Vaccine Adjuvants Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 11. Global Human Vaccine Adjuvants Sales by Manufacturer (2017-2022) & (Tons)
    Table 12. Global Human Vaccine Adjuvants Sales Share by Manufacturer (2017-2022)
    Table 13. Human Vaccine Adjuvants Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 14. Human Vaccine Adjuvants Revenue Share by Manufacturer (2017-2022)
    Table 15. Key Manufacturers Human Vaccine Adjuvants Price (2017-2022) & (US$/吨)
    Table 16. Ranking of Global Top Human Vaccine Adjuvants Manufacturers by Revenue (US$ Million) in 2021
    Table 17. Global Human Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 18. Global Human Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine Adjuvants as of 2021)
    Table 19. Human Vaccine Adjuvants Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Human Vaccine Adjuvants Product Type
    Table 21. Date of International Manufacturers Enter into Human Vaccine Adjuvants Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. GSK Corporation Information
    Table 24. GSK Description and Business Overview
    Table 25. GSK Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 26. GSK Human Vaccine Adjuvants Product
    Table 27. GSK Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 28. GSK Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 29. GSK Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 30. GSK Recent Development
    Table 31. CSL Limited Corporation Information
    Table 32. CSL Limited Description and Business Overview
    Table 33. CSL Limited Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 34. CSL Limited Human Vaccine Adjuvants Product
    Table 35. CSL Limited Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 36. CSL Limited Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 37. CSL Limited Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 38. CSL Limited Recent Development
    Table 39. Croda Corporation Information
    Table 40. Croda Description and Business Overview
    Table 41. Croda Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 42. Croda Human Vaccine Adjuvants Product
    Table 43. Croda Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 44. Croda Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 45. Croda Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 46. Croda Recent Development
    Table 47. SEPPIC Corporation Information
    Table 48. SEPPIC Description and Business Overview
    Table 49. SEPPIC Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 50. SEPPIC Human Vaccine Adjuvants Product
    Table 51. SEPPIC Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 52. SEPPIC Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 53. SEPPIC Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 54. SEPPIC Recent Development
    Table 55. Sanofi Corporation Information
    Table 56. Sanofi Description and Business Overview
    Table 57. Sanofi Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 58. Sanofi Human Vaccine Adjuvants Product
    Table 59. Sanofi Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 60. Sanofi Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 61. Sanofi Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 62. Sanofi Recent Development
    Table 63. Zhifei Biological Corporation Information
    Table 64. Zhifei Biological Description and Business Overview
    Table 65. Zhifei Biological Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 66. Zhifei Biological Human Vaccine Adjuvants Product
    Table 67. Zhifei Biological Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 68. Zhifei Biological Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 69. Zhifei Biological Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 70. Escon Corporation Information
    Table 71. Escon Description and Business Overview
    Table 72. Escon Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 73. Escon Human Vaccine Adjuvants Product
    Table 74. Escon Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 75. Escon Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 76. Escon Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 77. Huanuotai Biological Corporation Information
    Table 78. Huanuotai Biological Description and Business Overview
    Table 79. Huanuotai Biological Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 80. Huanuotai Biological Human Vaccine Adjuvants Product
    Table 81. Huanuotai Biological Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 82. Huanuotai Biological Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 83. Huanuotai Biological Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 84. Rico Bio Corporation Information
    Table 85. Rico Bio Description and Business Overview
    Table 86. Rico Bio Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2017-2022)
    Table 87. Rico Bio Human Vaccine Adjuvants Product
    Table 88. Rico Bio Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Product in 2021
    Table 89. Rico Bio Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Application in 2021
    Table 90. Rico Bio Human Vaccine Adjuvants Sales Proportion of Human Vaccine Adjuvants by Geographic Area in 2021
    Table 91. Global Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 92. Global Human Vaccine Adjuvants Sales Forecast by Type (2023-2028) & (Tons)
    Table 93. Global Human Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
    Table 94. Global Human Vaccine Adjuvants Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 95. Global Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 96. Global Human Vaccine Adjuvants Sales Forecast by Application (2023-2028) & (Tons)
    Table 97. Global Human Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
    Table 98. Global Human Vaccine Adjuvants Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 99. North America Human Vaccine Adjuvants Sales by Country (2017-2022) & (Tons)
    Table 100. North America Human Vaccine Adjuvants Sales by Country (2023-2028) & (Tons)
    Table 101. North America Human Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 102. North America Human Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 103. North America Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 104. North America Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 105. Asia-Pacific Human Vaccine Adjuvants Sales by Region (2017-2022) & (Tons)
    Table 106. Asia-Pacific Human Vaccine Adjuvants Sales by Region (2023-2028) & (Tons)
    Table 107. Asia-Pacific Human Vaccine Adjuvants Revenue by Region (2017-2028) & (US$ Million)
    Table 108. Asia-Pacific Human Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
    Table 109. Asia-Pacific Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 110. Asia-Pacific Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 111. Europe Human Vaccine Adjuvants Sales by Country (2017-2022) & (Tons)
    Table 112. Europe Human Vaccine Adjuvants Sales by Country (2023-2028) & (Tons)
    Table 113. Europe Human Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 114. Europe Human Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 115. Europe Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 116. Europe Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 117. Latin America Human Vaccine Adjuvants Sales by Country (2017-2022) & (Tons)
    Table 118. Latin America Human Vaccine Adjuvants Sales by Country (2023-2028) & (Tons)
    Table 119. Latin America Human Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 120. Latin America Human Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 121. Latin America Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 122. Latin America Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 123. Middle East and Africa Human Vaccine Adjuvants Sales by Country (2017-2022) & (Tons)
    Table 124. Middle East and Africa Human Vaccine Adjuvants Sales by Country (2023-2028) & (Tons)
    Table 125. Middle East and Africa Human Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
    Table 126. Middle East and Africa Human Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
    Table 127. Middle East and Africa Human Vaccine Adjuvants Sales by Type (2017-2022) & (Tons)
    Table 128. Middle East and Africa Human Vaccine Adjuvants Sales by Application (2017-2022) & (Tons)
    Table 129. Human Vaccine Adjuvants Key Raw Materials, Industry Status and Trend
    Table 130. Human Vaccine Adjuvants Key Raw Materials and Upstream Suppliers
    Table 131. Human Vaccine Adjuvants Clients Status and Trend
    Table 132. Human Vaccine Adjuvants Typical Clients
    Table 133. Human Vaccine Adjuvants Distributors
    Table 134. Human Vaccine Adjuvants Market Trends
    Table 135. Human Vaccine Adjuvants Market Drivers
    Table 136. Human Vaccine Adjuvants Market Challenges
    Table 137. Human Vaccine Adjuvants Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Vaccine Adjuvants Product Picture
    Figure 2. Global Human Vaccine Adjuvants Sales Market Share by Type in 2021 & 2028
    Figure 3. Aluminium Salt Adjuvant Product Picture
    Figure 4. Oil Emulsion Adjuvant Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Human Vaccine Adjuvants Sales Market Share by Application in 2021 & 2028
    Figure 7. Commercial Examples
    Figure 8. Research Examples
    Figure 9. Human Vaccine Adjuvants Report Years Considered
    Figure 10. Global Human Vaccine Adjuvants Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Human Vaccine Adjuvants Market Size 2017-2028 (US$ Million)
    Figure 12. Global Human Vaccine Adjuvants Sales 2017-2028 (Tons)
    Figure 13. Global Human Vaccine Adjuvants Market Size Market Share by Region: 2022 Versus 2028
    Figure 14. Global Human Vaccine Adjuvants Sales Market Share Forecast by Region (2017-2028)
    Figure 15. Global Human Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
    Figure 16. Global Human Vaccine Adjuvants Sales Share by Manufacturer in 2021
    Figure 17. Human Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Human Vaccine Adjuvants Sales Market Share Forecast by Type (2017-2028)
    Figure 19. Global Human Vaccine Adjuvants Revenue Market Share Forecast by Type (2017-2028)
    Figure 20. Human Vaccine Adjuvants Average Selling Price (ASP) by Type (2017-2022) & (US$/吨)
    Figure 21. Global Human Vaccine Adjuvants Sales Market Share Forecast by Application (2017-2028)
    Figure 22. Global Human Vaccine Adjuvants Revenue Market Share Forecast by Application (2017-2028)
    Figure 23. Human Vaccine Adjuvants Average Selling Price (ASP) by Application (2017-2022) & (US$/吨)
    Figure 24. North America Human Vaccine Adjuvants Revenue 2017-2028 (US$ Million)
    Figure 25. North America Human Vaccine Adjuvants Sales Market Share by Type (2017-2022)
    Figure 26. North America Human Vaccine Adjuvants Sales Market Share by Application (2017-2022)
    Figure 27. Asia-Pacific Human Vaccine Adjuvants Revenue 2017-2028 (US$ Million)
    Figure 28. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Region (2017-2028)
    Figure 29. Asia-Pacific Human Vaccine Adjuvants Revenue Market Share by Region (2017-2028)
    Figure 30. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Type (2017-2022)
    Figure 31. Asia-Pacific Human Vaccine Adjuvants Sales Market Share by Application (2017-2022)
    Figure 32. Europe Human Vaccine Adjuvants Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 33. Europe Human Vaccine Adjuvants Sales Market Share by Country (2017-2028)
    Figure 34. Europe Human Vaccine Adjuvants Revenue Market Share by Country (2017-2028)
    Figure 35. Europe Human Vaccine Adjuvants Sales Market Share by Type (2017-2022)
    Figure 36. Europe Human Vaccine Adjuvants Sales Market Share by Application (2017-2022)
    Figure 37. Latin America Human Vaccine Adjuvants Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 38. Latin America Human Vaccine Adjuvants Sales Market Share by Country (2017-2028)
    Figure 39. Latin America Human Vaccine Adjuvants Revenue Market Share by Country (2017-2022)
    Figure 40. Latin America Human Vaccine Adjuvants Sales Market Share by Type (2017-2022)
    Figure 41. Latin America Human Vaccine Adjuvants Sales Market Share by Application (2017-2022)
    Figure 42. Middle East and Africa Human Vaccine Adjuvants Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 43. Middle East and Africa Human Vaccine Adjuvants Sales Market Share by Country (2017-2028)
    Figure 44. Middle East and Africa Human Vaccine Adjuvants Revenue Market Share by Country (2017-2028)
    Figure 45. Middle East and Africa Human Vaccine Adjuvants Sales Market Share by Type (2017-2022)
    Figure 46. Middle East and Africa Human Vaccine Adjuvants Sales Market Share by Application (2017-2022)
    Figure 47. Human Vaccine Adjuvants Supply Chain (Upstream and Downstream Market)
    Figure 48. Global Production Market Share of Human Vaccine Adjuvants Raw Materials by Region in 2021
    Figure 49. Human Vaccine Adjuvants Distribution Channels
    Figure 50. Global Human Vaccine Adjuvants Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 51. Global Human Vaccine Adjuvants Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS